查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1798028

2032 年抗衰老治疗市场预测：按衰老类型、分子类型、作用机制、药物类别、分销管道、应用和地区进行的全球分析

Anti-aging Therapeutics Market Forecasts to 2032 - Global Analysis By Type of Aging, Type of Molecule, Mechanism of Action, Drug Class, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球抗衰老治疗市场预计在 2025 年达到 9.9112 亿美元，到 2032 年将达到 34.734 亿美元，预测期内的复合年增长率为 19.62%。

抗衰老疗法是指旨在预防、减缓或逆转与老化相关的生物过程的疗法、干预措施和产品。这些疗法旨在透过针对导致老化的细胞损伤、氧化压力、发炎和遗传因素，延长健康寿命、改善外观并维持生理功能。这些疗法包括药物、生技药品、再生疗法、荷尔蒙替代疗法和营养补充剂。抗衰老疗法还可以治疗与年龄相关的疾病，例如心血管疾病、神经退化和骨质疏鬆症。

生物技术和基因组学的进展

精准医疗技术透过根据患者的基因组成客製化治疗方法，提高了安全性和有效性。基因编辑、干细胞疗法和再生医学的进展为修復细胞损伤和延缓老化提供了新的方法。基因组研究透过辨识生物标记和老化相关基因，加速了新药的研发。这些进展减少了治疗方法设计中的试验，并加快了成功治疗方法的上市速度。

缺乏长期临床证据

由于长期疗效未经证实，消费者对产品的有效性持续存疑。由于数据不足，产品难以获得监管部门的核准。投资者可能不愿意为缺乏强有力临床支持的项目提供资金。这导致新治疗方法的研发和上市受到拖延。

提高消费者意识并专注于预防性护理

越来越多的人正在寻求保持健康和青春的方法。那些具有预防性健康观念的人更有可能在註意到明显的衰老迹象之前就开始治疗。这种观念的转变推动了尖端抗衰老疗法和解决方案的早期采用。市场扩张也得益于人们对活性成分和精良配方益处的日益认识。因此，各公司正集中行销和研发力量，以服务于这群精明的客户群。

治疗费用高且报销有限

相当一部分人口仍然无力承担许多先进的治疗。有限的保险覆盖和报销规定进一步加重了患者的经济负担，阻碍了他们接受美容和预防性护理。因此，高所得群体仍是最大的需求群体。这些经济障碍阻碍了整体市场的扩张和可近性。

COVID-19的影响

新冠疫情爆发严重衝击了抗衰老治疗市场，扰乱了供应链，推迟了临床试验，并影响了生产业务。选择性和非紧急治疗的限制导致患者就诊量减少，产品采用速度放缓。然而，这场危机也间接地支持了市场的长期成长，因为它提升了消费者对健康、保健和预防保健的兴趣。向远端医疗和数位平台的转变使得人们能够持续获得咨询和产品资讯。疫情后的復苏将受到对先进抗衰老解决方案需求的復苏、研发投入的增加以及美容和治疗程序的恢復的推动。

预计细胞衰老领域将成为预测期内最大的细分市场

预计细胞老化领域将在预测期内占据最大的市场占有率，该领域针对的是细胞层面老化的根本原因，例如DNA损伤、端粒缩短和氧化压力。抗衰老药物、端粒酶激活剂和细胞再生疗法的创新正在推动对先进解决方案的需求。针对细胞修復机制的研究投入和临床试验的增加，进一步推动了市场的成长。消费者对预防性医疗保健和长寿意识的不断提高，推动了这些治疗方法的采用。因此，细胞衰老领域对整个抗衰老治疗市场的扩张做出了重大贡献。

预计认知功能部分将在预测期内实现最高的复合年增长率

认知功能领域预计将在预测期内实现最高成长率，因为它致力于解决与老化相关的记忆力、注意力和思维敏锐度的下降。人们对阿兹海默症和失智症神经退化性疾病的认识不断提高，推动了对预防和治疗解决方案的需求。趋向性、神经保护药物和再生疗法的进展正在拓宽治疗选择。大脑健康补充剂和生活方式干预措施的日益普及，进一步推动了市场成长。认知增强研究和临床试验的不断增加，正在增强该领域对整个抗衰老市场的贡献。

比最大的地区

预计北美地区将在预测期内占据最大的市场占有率，这得益于与生活方式相关的衰老疾病的高发性、强大的医疗基础设施以及对先进再生药物不断增长的需求。干细胞疗法、基因编辑和胜肽疗法等技术正日益受到重视。新兴趋势包括个人化抗衰老解决方案和人工智慧主导的早期疗育诊断。关键进展包括生物技术公司与研究机构在新型药物传输系统的合作。

复合年增长率最高的地区

预计亚太地区将在预测期内实现最高的复合年增长率，这得益于人口老化、可支配收入成长以及预防保健意识的增强。奈米医学、草药疗法和微生物组调节等技术正在兴起。趋势包括传统医学与现代医学的融合以及对非侵入性治疗的需求。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场参与企业进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 透过产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 介绍
  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球抗老治疗市场（依老化类型）

  • 介绍
  • 细胞老化
  • 免疫老化
  • 代谢性衰老
  • 其他类型的衰老

6. 全球抗衰老治疗市场（按分子类型）

  • 介绍
  • 生技药品
  • 小分子

7. 全球抗衰老治疗市场（按作用机制）

  • 介绍
  • 老化抑制剂
  • 细胞再生
  • mTor调变器
  • AMPK激活剂
  • 端粒酶激活剂
  • 其他作用机制

8. 全球抗老治疗市场（依药物类别）

  • 介绍
  • 荷尔蒙疗法
  • 抗氧化剂
  • 酵素
  • 干细胞疗法
  • 其他的

9. 全球抗衰老治疗市场（按分销管道）

  • 介绍
  • 医院药房
  • 零售药局
  • 线上平台

第 10 章全球抗衰老治疗市场（按应用）

  • 介绍
  • 皮肤和头髮健康
  • 骨骼和肌肉健康
  • 认知功能
  • 与年龄相关的疾病
  • 其他的

第 11 章全球抗衰老治疗市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章：企业概况

  • Unity BIoTechnology
  • Novartis AG
  • Roche Holding AG
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Sun Pharmaceutical Industries Ltd.
  • Elysium Health
  • Insilico Medicine
  • AgeX Therapeutics
  • Senolytic Therapeutics, Inc.
  • BioViva
  • Rejuvenate Bio
  • Calico Life Sciences
  • Altos Labs
Product Code: SMRC30398

According to Stratistics MRC, the Global Anti-aging Therapeutics Market is accounted for $991.12 million in 2025 and is expected to reach $3473.40 million by 2032 growing at a CAGR of 19.62% during the forecast period. Anti-aging therapeutics refers to medical treatments, interventions, and products designed to prevent, slow down, or reverse the biological processes associated with aging. This therapeutics aims to improve health span, enhance physical appearance, and maintain physiological functions by targeting cellular damage, oxidative stress, inflammation, and genetic factors that contribute to aging. They include pharmaceuticals, biologics, regenerative therapies, hormone replacements, and nutraceuticals. Anti-aging therapeutics may also address age-related diseases such as cardiovascular disorders, neurodegeneration, and osteoporosis.

Market Dynamics:

Driver:

Advancements in biotechnology & genomics

Precision medicine techniques improve safety and efficacy by customizing therapies to a patient's genetic composition. New approaches to repairing cellular damage and delaying ageing processes are provided by advances in gene editing, stem cell treatment, and regenerative medicine. The identification of biomarkers and aging-related genes through genomic research speeds up the creation of new drugs. These developments speed up the release of successful treatments onto the market by reducing trial-and-error in therapeutic design.

Restraint:

Lack of long-term clinical evidence

Customers continue to doubt the efficacy of products in the absence of substantiated long-term outcomes. Regulatory approvals are difficult to get because of inadequate data. Without strong clinical support, investors might be reluctant to fund ideas. Research, development, and the launch of novel treatments are slowed down as a result.

Opportunity:

Rising consumer awareness & preventive health attitudes

More and more people are looking for ways to stay healthy and look young. People who have preventive health attitudes are more likely to start therapies before they notice obvious symptoms of ageing. This mentality change encourages the early uptake of cutting-edge anti-aging treatments and solutions. Market expansion is also supported by growing awareness of the advantages of active substances and sophisticated formulations. Consequently, businesses are concentrating on marketing and research to serve this knowledgeable customer base.

Threat:

High treatment costs & limited reimbursement

A sizable section of the population still cannot afford many sophisticated therapies. Patients are further burdened financially by limited insurance coverage or reimbursement rules. This deters people from getting cosmetic or preventative care. As a result, high-income groups continue to have the greatest demand. These monetary obstacles impede the market's overall expansion and accessibility.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Anti-aging Therapeutics Market, disrupting supply chains, delaying clinical trials, and affecting manufacturing operations. Restrictions on elective and non-urgent treatments led to reduced patient visits, slowing product adoption. However, the crisis heightened consumer focus on health, wellness, and preventive care, indirectly supporting long-term market growth. The shift toward telemedicine and digital platforms enabled continued access to consultations and product information. Post-pandemic recovery is driven by renewed demand for advanced anti-aging solutions, increased R&D investment, and the resumption of aesthetic and therapeutic procedures.

The cellular aging segment is expected to be the largest during the forecast period

The cellular aging segment is expected to account for the largest market share during the forecast period by targeting the root causes of aging at the cellular level, such as DNA damage, telomere shortening, and oxidative stress. Innovations in senolytics, telomerase activators, and cell regeneration therapies are driving demand for advanced solutions. Growing research investments and clinical trials focusing on cellular repair mechanisms further accelerate market growth. Rising consumer awareness about preventive healthcare and longevity enhances adoption of these therapies. As a result, the cellular aging segment is becoming a key contributor to the overall expansion of the anti-aging therapeutics market.

The cognitive function segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive function segment is predicted to witness the highest growth rate due to addressing age-related decline in memory, focus, and mental clarity. Growing awareness about neurodegenerative diseases like Alzheimer's and dementia drives demand for preventive and therapeutic solutions. Advancements in no tropics, neuroprotective drugs, and regenerative therapies are expanding treatment options. Rising adoption of brain health supplements and lifestyle interventions further boosts market growth. Increasing research and clinical trials in cognitive enhancement strengthen the segment's contribution to the overall anti-aging market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share is driven by a high prevalence of lifestyle-related aging disorders, strong healthcare infrastructure, and growing demand for advanced regenerative medicine. Technologies such as stem cell therapy, gene editing, and peptide-based treatments are gaining prominence. Emerging trends include personalized anti-aging solutions and AI-driven diagnostics for early intervention. Key developments involve collaborations between biotech firms and research institutions for novel drug delivery systems.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR is fuelled by a rising aging population, increasing disposable incomes, and growing awareness of preventive healthcare. Technologies like nanomedicine, herbal-based therapeutics, and microbiome modulation are emerging. Trends include integration of traditional medicine with modern therapies and demand for non-invasive treatments.

Key players in the market

Some of the key players in Anti-aging Therapeutics Market include Unity Biotechnology, Novartis AG, Roche Holding AG, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., AstraZeneca plc, Johnson & Johnson, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Elysium Health, Insilico Medicine, AgeX Therapeutics, Senolytic Therapeutics, Inc., BioViva, Rejuvenate Bio, Calico Life Sciences and Altos Labs.

Key Developments:

In February 2025, Novartis acquired Anthos Therapeutics for US $925 million upfront, plus up to $2.15 billion in milestones. The acquisition secured abelacimab, a Factor XI inhibitor in Phase 3 trials for stroke prevention in atrial fibrillation, addressing a major cardiovascular risk predominantly affecting older adults.

In December 2024, Novartis entered a multi-year partnership with BioAge Labs to co discover novel therapeutic targets addressing age related diseases. Novartis provided up to US $20 M in upfront funding, while BioAge can earn up to $530 M in milestone payments.

In May 2024, Merck announced plans to acquire UK-based Eyebiotech (EyeBio), developer of Restoret/MK 3000 for age-related macular degeneration and diabetic macular edema. The agreement included $1.3 billion upfront and up to $1.7 billion in contingent milestone payments, totaling approximately $3 billion, strengthening Merck's portfolio in age-related eye disease therapies.

Type of Aging Covered:

  • Cellular Aging
  • Immune Aging
  • Metabolic Aging
  • Other Type of Aging

Type of Molecules Covered:

  • Biologics
  • Small Molecules

Mechanism of Actions Covered:

  • Senolytics
  • Cell Regeneration
  • mTor Modulators
  • AMPK Activators
  • Telomerase Activators
  • Other Mechanism of Actions

Drug Classes Covered:

  • Hormonal Therapy
  • Antioxidants
  • Enzymes
  • Stem Cell Therapy
  • Other Drug Classes

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platforms

Applications Covered:

  • Skin & Hair Health
  • Skeletal & Muscular Health
  • Cognitive Function
  • Age-related Disorders
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Anti-aging Therapeutics Market, By Type of Aging

  • 5.1 Introduction
  • 5.2 Cellular Aging
  • 5.3 Immune Aging
  • 5.4 Metabolic Aging
  • 5.5 Other Types of Aging

6 Global Anti-aging Therapeutics Market, By Type of Molecule

  • 6.1 Introduction
  • 6.2 Biologics
  • 6.3 Small Molecules

7 Global Anti-aging Therapeutics Market, By Mechanism of Action

  • 7.1 Introduction
  • 7.2 Senolytics
  • 7.3 Cell Regeneration
  • 7.4 mTor Modulators
  • 7.5 AMPK Activators
  • 7.6 Telomerase Activators
  • 7.7 Other Mechanism of Actions

8 Global Anti-aging Therapeutics Market, By Drug Class

  • 8.1 Introduction
  • 8.2 Hormonal Therapy
  • 8.3 Antioxidants
  • 8.4 Enzymes
  • 8.5 Stem Cell Therapy
  • 8.6 Other Drug Classes

9 Global Anti-aging Therapeutics Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Hospital Pharmacies
  • 9.3 Retail Pharmacies
  • 9.4 Online Platforms

10 Global Anti-aging Therapeutics Market, By Application

  • 10.1 Introduction
  • 10.2 Skin & Hair Health
  • 10.3 Skeletal & Muscular Health
  • 10.4 Cognitive Function
  • 10.5 Age-related Disorders
  • 10.6 Other Applications

11 Global Anti-aging Therapeutics Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Unity Biotechnology
  • 13.2 Novartis AG
  • 13.3 Roche Holding AG
  • 13.4 Merck & Co., Inc.
  • 13.5 Pfizer Inc.
  • 13.6 Sanofi S.A.
  • 13.7 AstraZeneca plc
  • 13.8 Johnson & Johnson
  • 13.9 Abbott Laboratories
  • 13.10 Sun Pharmaceutical Industries Ltd.
  • 13.11 Elysium Health
  • 13.12 Insilico Medicine
  • 13.13 AgeX Therapeutics
  • 13.14 Senolytic Therapeutics, Inc.
  • 13.15 BioViva
  • 13.16 Rejuvenate Bio
  • 13.17 Calico Life Sciences
  • 13.18 Altos Labs

List of Tables

  • Table 1 Global Anti-aging Therapeutics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Anti-aging Therapeutics Market Outlook, By Type of Aging (2024-2032) ($MN)
  • Table 3 Global Anti-aging Therapeutics Market Outlook, By Cellular Aging (2024-2032) ($MN)
  • Table 4 Global Anti-aging Therapeutics Market Outlook, By Immune Aging (2024-2032) ($MN)
  • Table 5 Global Anti-aging Therapeutics Market Outlook, By Metabolic Aging (2024-2032) ($MN)
  • Table 6 Global Anti-aging Therapeutics Market Outlook, By Other Types of Aging (2024-2032) ($MN)
  • Table 7 Global Anti-aging Therapeutics Market Outlook, By Type of Molecule (2024-2032) ($MN)
  • Table 8 Global Anti-aging Therapeutics Market Outlook, By Biologics (2024-2032) ($MN)
  • Table 9 Global Anti-aging Therapeutics Market Outlook, By Small Molecules (2024-2032) ($MN)
  • Table 10 Global Anti-aging Therapeutics Market Outlook, By Mechanism of Action (2024-2032) ($MN)
  • Table 11 Global Anti-aging Therapeutics Market Outlook, By Senolytics (2024-2032) ($MN)
  • Table 12 Global Anti-aging Therapeutics Market Outlook, By Cell Regeneration (2024-2032) ($MN)
  • Table 13 Global Anti-aging Therapeutics Market Outlook, By mTor Modulators (2024-2032) ($MN)
  • Table 14 Global Anti-aging Therapeutics Market Outlook, By AMPK Activators (2024-2032) ($MN)
  • Table 15 Global Anti-aging Therapeutics Market Outlook, By Telomerase Activators (2024-2032) ($MN)
  • Table 16 Global Anti-aging Therapeutics Market Outlook, By Other Mechanism of Actions (2024-2032) ($MN)
  • Table 17 Global Anti-aging Therapeutics Market Outlook, By Drug Class (2024-2032) ($MN)
  • Table 18 Global Anti-aging Therapeutics Market Outlook, By Hormonal Therapy (2024-2032) ($MN)
  • Table 19 Global Anti-aging Therapeutics Market Outlook, By Antioxidants (2024-2032) ($MN)
  • Table 20 Global Anti-aging Therapeutics Market Outlook, By Enzymes (2024-2032) ($MN)
  • Table 21 Global Anti-aging Therapeutics Market Outlook, By Stem Cell Therapy (2024-2032) ($MN)
  • Table 22 Global Anti-aging Therapeutics Market Outlook, By Other Drug Classes (2024-2032) ($MN)
  • Table 23 Global Anti-aging Therapeutics Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 24 Global Anti-aging Therapeutics Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 25 Global Anti-aging Therapeutics Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 26 Global Anti-aging Therapeutics Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 27 Global Anti-aging Therapeutics Market Outlook, By Application (2024-2032) ($MN)
  • Table 28 Global Anti-aging Therapeutics Market Outlook, By Skin & Hair Health (2024-2032) ($MN)
  • Table 29 Global Anti-aging Therapeutics Market Outlook, By Skeletal & Muscular Health (2024-2032) ($MN)
  • Table 30 Global Anti-aging Therapeutics Market Outlook, By Cognitive Function (2024-2032) ($MN)
  • Table 31 Global Anti-aging Therapeutics Market Outlook, By Age-related Disorders (2024-2032) ($MN)
  • Table 32 Global Anti-aging Therapeutics Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.